• CHI3L1-IN-5: From Target Binding to Astrocyte Rescue

  2026-09-02

  CHI3L1-IN-5 (Compound Z17) is a CNS-penetrant CHI3L1 inhibitor that links direct target engagement with NF-κB suppression, astrocyte Aβ uptake restoration, and lysosomal recovery. This article presents a practical evidence framework for interpreting its mechanism and designing translational neuroinflammation assays.

• OSMI-1 and the Translational Logic of O-GlcNAc

  2026-09-01

  The emerging O-GlcNAc–HUWE1–TfR1 axis connects protein modification with placental iron handling, ferroptosis, and trophoblast syncytialization. This thought-leadership guide explains how OSMI-1, a cell-permeable O-GlcNAc transferase inhibitor, can serve as a carefully controlled loss-of-function tool for testing that model while keeping cytotoxicity and translational limitations in view.

• Carvedilol in β-Adrenergic Receptor Research

  2026-09-01

  Carvedilol combines nonselective β-adrenergic blockade with α1-adrenergic antagonism, antioxidant activity, and anti-proliferative effects, enabling one compound to support cardiovascular, vascular, and hematopoietic studies. Its comparison with β1-selective inhibition also provides a practical framework for dissecting receptor selectivity after hematopoietic cell transplantation.

• Myelin Damage Can Remodel Before Sheath Loss

  2026-08-31

  A 2026 Science study shows that early CNS myelin damage is marked by swelling that can resolve rather than inevitably progressing to sheath loss. Across zebrafish, rodent, and human material, the work identifies neuronal activity as a modifiable factor that worsens swelling and reduces oligodendrocyte survival, highlighting an early window for protecting myelin.

• Rotigotine: From Receptor Biology to Translation

  2026-08-30

  A translational framework for using Rotigotine to connect dopamine receptor pharmacology, continuous dopaminergic delivery, neuroprotection assays, animal models, and clinically relevant Parkinson’s disease and restless legs syndrome research.

• Cy7 NHS Ester: Practical Labeling and QC Guide

  2026-08-29

  Cy7 NHS ester is a water-soluble near-infrared dye for bioimaging that enables labeling of accessible amino groups on proteins and peptides, including targets that may be sensitive to organic co-solvents. It is suited to fresh in vitro or in vivo labeling workflows, but not to molecules lacking accessible amines or to experiments requiring long-term storage of prepared dye solutions.

• RNA Pol II Inhibition Activates Regulated Apoptosis

  2026-08-29

  Harper et al. show that RNA polymerase II inhibition kills cells through an active apoptotic program rather than through passive loss of mRNA and protein. Their work identifies depletion of hypophosphorylated RNA Pol IIA and defines a Pol II degradation-dependent apoptotic response that connects nuclear perturbation to mitochondrial cell death.

• Propranolol Workflows for β-Receptor Research

  2026-08-28

  Propranolol enables integrated studies of β1/β2 adrenergic signaling, from cardiovascular regulation and metabolic assays to emotional memory modulation and essential tremor therapy. This practical guide connects formulation, assay design, TMS-informed neurophysiology, and troubleshooting for more reproducible translational experiments.

• CLK2 and Platinum Resistance in Ovarian Cancer

  2026-08-28

  The reference study identifies Cdc2-like kinase 2 (CLK2) as a clinically relevant driver of platinum resistance in ovarian cancer and links this phenotype to BRCA1 Ser1423 phosphorylation and DNA-damage repair. Its integrated tissue, cellular, mechanistic, and xenograft experiments provide a framework for evaluating CLK2 as a resistance target while clarifying why family-level kinase tools require careful interpretation.

• Ciclesonide and the Next Logic of Precision Degradation

  2026-08-27

  Ciclesonide illustrates how prodrug activation can concentrate glucocorticoid activity in the lung, while new ERAD-engaging chimeras suggest a separate strategy for degrading difficult membrane proteins. This translational analysis connects the two ideas without confusing established respiratory pharmacology with an unvalidated degradation application.

• LMO2–LDB1 Signaling in Acute Myeloid Leukemia

  2026-08-27

  The reference study identifies an LMO2/LDB1 protein complex as a functional driver of acute myeloid leukemia (AML) cell proliferation and survival. By combining gene perturbation, protein-interaction analysis, RNA-seq, ChIP-seq, and in vivo validation, the work connects LDB1-dependent transcriptional regulation with LMO2-mediated leukemic maintenance and suggests a potential therapeutic vulnerability.

• HyperScribe Co-transcription mRNA Synthesis Kit Plus

  2026-08-26

  The HyperScribe Co-transcription mRNA Synthesis Kit Plus supports controlled ARCA-capped and polyadenylated mRNA production for translation, RNA vaccine development, and mechanistic studies. This article focuses on how cap orientation, template architecture, and assay design determine whether an mRNA experiment produces interpretable biological data.

• Balsalazide Disodium: IBD Research Workflows

  2026-08-26

  Balsalazide disodium supports complementary ulcerative-colitis workflows, from bacterial activation and immunology assays to radiolabeled colon imaging. This guide translates published labeling conditions into practical setup, optimization, and troubleshooting decisions for reproducible inflammation research.

• HyperScribe T7 High Yield Cy3 RNA Labeling Kit Plus

  2026-08-25

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus provides a defined in vitro transcription workflow for producing randomly Cy3-modified RNA probes for fluorescence-based detection. It is intended for research applications such as in situ hybridization and Northern blot hybridization, and should not be used for diagnostic, therapeutic, or other medical purposes.

• Psora 4: From Blockade to Assay Interpretation

  2026-08-25

  Psora 4 is a Kv1.3 blocker for dissecting T-cell calcium signaling, effector-memory biology, and inflammatory disease models. This article focuses on a frequently overlooked variable—KCNE4-dependent channel architecture—and shows how it should shape assay design, controls, and interpretation.

452 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page